Invasive fungal infections: A diagnostic challenge

Abstract

Introduction: Overall incidence of invasive fungal infections in solid organ transplant recipients is low with the more common infections being invasive candidiasis, aspergillosis and cryptococosis. Zygomycosis comprises of only 0.2%-1.2% of infections in renal transplant recipients with current recommendations advising against routine prophylaxis.

Case: The patient was a 60-year-old male with a history of renal transplant 25 years ago on immunosuppressants, chronic transplant glomerulopathy, squamous cell carcinoma post penectomy and bilateral orchiectomy 2 years ago, controlled diabetes and hypertension who presented with pain in the perineal region for 4 days. On exam he was discovered to be afebrile and had a scrotal skin fold with urethral opening from his previous surgery and 2.5 cm induration and tenderness in the left gluteal fold. He was treated with 5 days of Unasyn. A biopsy was taken to rule out recurrence of squamous cell carcinoma and he was discharged home. The patient returned with worsening perineal pain within 3 days. On exam he had progressive induration with erythema, swelling and tenderness in the perineum. An initial white blood cell count of 15.8 increased to 25.8 and blood cultures remained negative. The computed tomography scan showed diffuse edema in the perineum without any evidence of abscesses. Immunosuppression was held and broad spectrum antibiotics were started. His renal failure progressively worsened eventually requiring continuous renal replacement therapy, intensive care transfer and vasopressor support. The biopsy revealed intermingled fibrous tissue with focal necrosis and no evidence of malignant cells. A repeat incision and debridement (I&D) culture showed growth consistent with mucor. He was started on liposomal amphotericin B and taken to the OR for multiple debridements. Unfortunately he progressed to multisystem organ failure and died after transitioning to comfort care.

Conclusions: Invasive fungal infections remain one of the life threatening differentials for cellulitis like skin lesions, especially for patients not responding to antibiotics and those who are immunocompromised. Early cultures and histopathology of lesions should be done for diagnosis and to avoid delays in treatment.

Keywords

Invasive fungal infections / Solid organ transplant / Mucor / Immunosuppression

References

[1] Santos T, Aguiar B, Santos L, et al. Invasive fungal infections after kidney transplantation: A single-center experience. Transplant Proc. 2015; 47(4): 971-5. PMid:26036497. https://doi.org/10.1016/j.transproceed.2015.03.040

[2] Petrikkos G, Skiada A, Lortholary O, et al. Epidemiology and clinical manifestations of mucormycosis. Clinical Infectious Diseases. 2012; 54 (1): S23-34. PMid: 22247442. https://doi.org/10.1093/cid/cir866

[3] Chkhotua A, Yussim A, Tovar A, et al. Mucormycosis of the renal allograft: case report and review of the literature. Transpl Int. 2001; 14(6): 438-41. PMid:11793042. https://doi.org/10.1111/j.1432-2277.2001.tb00083.x

[4] Nampoory MR, Khan ZU, Johny KV, et al. Invasive fungal infections in renal transplant recipients. J Infect. 1996; 33(2): 95-101. https://doi.org/10.1016/S0163-4453(96)92986-2

[5] Park BJPP, Wannemuehler KA, Alexander BP, et al. Invasive non aspergillus mold infections in transplant recipients, United States, 2001-2006. Emerg Infect Dis. 2011; 17: 1855-64. PMid: 22000355. https://doi.org/10.3201/eid1710.110087

[6] Hamdi T, Karthikeyan V, Alangaden GJ. Mucormycosis in a renal transplant recipient: case report and comprehensive review of literature. International Journal of Nephrology. 2014; 1-8. PMid: 24688793. https://doi.org/10.1155/2014/950643

[7] Pappas PG, Alexander BD, Andes DR, et al. Invasive fungal infec-tions among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis. 2010; 50: 1101-11. PMid: 20218876. https://doi.org/10.1086/651262

[8] Godara SM, Kute VB, Goplani KR, et al. Mucormycosis in renal transplant recipients: predictors and outcome. Saudi J Kidney Dis Transpl. 2011; 22(4): 751-6. PMid: 21743222.

[9] Fungal infections. American Journal of Transplantation. 2004; Suppl, vol. 4, supplement 10: 110-134. https://doi.org/10.1111/j.1600-6135.2004.00735.x

[10] Green JP, Karras DJ. Update on emerging infections: news from the centers for disease control and prevention. Annals of Emergency Medicine. 2012; 59: 53-54. PMid: 22177678.

[11] Xhaard AL, Porcher R, Dannnaoui E, et al. Mucormycosis after allogenic hematopoietic stem cell transplantation: a French Multicenter cohort study (2003-2008). Clin Microbiol Infect; revised.

[12] Aberer W, Konrad K, Wolff K. Wells’ syndrome is a distinctive disease entitiy and not a histologic diagnosis. J Am Acad Dermatol. 1988; 18: 105-114. https://doi.org/10.1016/S0190-962 2(88)70016-X

[13] Callen JP. Neutrophilic dermatoses. Dermatol Clin. 2002; 20: 409-419. https://doi.org/10.1016/S0733-8635(02)00006-2

[14] Fine A, Zacharias J. Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy. Kidney Int. 2002; 61: 2210-2217. PMid: 12028462. https://doi.org/10.1046/j.1523-1755.2002.00375.x

[15] Falagas ME, Vergidis PI. Narrative review: diseases that masquerade as infectious cellulitis. Ann Intern Med. 2005; 142: 47-55. https://doi.org/10.7326/0003-4819-142-1-200501040-00011

[16] Fitzpatrick TB, Johnson RA, Wolff K. Color atlas & synopsis of clinical dermatology: common and serious diseases. 4th ed. New York, NY: The McGraw-Hill Companies; 2001.

[17] Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005; 41: 634-53. PMid: 16080086. https://doi.org/10.1086/432579

[18] Almyroudis NG, Sutton DA, Linden P, et al. Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant. 2006; 6: 2365-74. PMid: 16925570. https://doi.org/10.1111/j.1600-6143.2006.01496.x

[19] Chakrabarti A, Chatterjee SS, Das A, et al. Invasive zygomycosis in India: experience in a tertiary care hospital. Postgrad Med J. 2009; 85: 573-81. PMid: 19892892. https://doi.org/10.1136/pgmj.2008.076463

[20] Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B based frontline therapy significantly increases mortality among patients with hematological malignancy who have zygomycosis. Clin Infect Dis. 2008; 47: 503-9. PMid: 18611163. https://doi.org/10.1086/590004